Sun Pharma Rises After Settling Patent Litigation With Actavis

October 24, 2015by prometheusip0

As part of the agreement, Ranbaxy along with its partners Cipher Pharm and Galephar Pharma, has entered into a non-exclusive license agreement with Actavis under the Dublin-headquartered company may start selling its generic version of Absorica in the US on 27 December 2020 (nine months before the expiration of the patents in September 2021) or earlier under certain circumstances, Sun Pharma said.

prometheusip

prometheusip

Prometheus IP is a leading intellectual property service enterprise offering competent and economic Intellectual Property Rights (IPR) solutions which include Patents, Designs, Copyrights and Trademarks.

Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:34B, Sai Dwaraka Sinman,
Huda Heights, Near Lotuspond, MLA Colony
Road No.12, Banjara Hills,Hyderabad-500034
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:34B, Sai Dwaraka Sinman,
Huda Heights, Near Lotuspond, MLA Colony
Road No.12, Banjara Hills,Hyderabad-500034
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social

Copyright Prometheus IP. All rights reserved.

Copyright Prometheus IP. All rights reserved.